Showing results (201-210 of 308) with videos related to

Sort By:
Pageof 31
Oncotarget|February 14, 2018
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinomaRei Suzuki, Hiroyuki Asama, Yuichi Waragai, et al.
World Journal of Gastroenterology|September 3, 2009
Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cavaYoshito Tomimaru, Hiroaki Nagano, Shigeru Marubashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resectionTakehiro Noda, Hirofumi Yamamoto, Ichiro Takemasa, et al.
Digestive Diseases and Sciences|September 29, 2011
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumorMasaru Kubota, Takamichi Murakami, Hiroaki Nagano, et al.
Oncology|February 12, 2020
"Logic-Based Medicine" Is More Feasible than "Evidence-Based Medicine" in the Local Treatment for Hepatocellular CarcinomaMasato Sakon, Shogo Kobayashi, Hiroshi Wada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of hepatic resection after chemotherapy for metastatic colon cancer of the liver with invasion of the inferior vena cava and hepatic vein]Hisateru Komatsu, Akira Tomokuni, Hiroshi Wada, et al.
The Journal of Surgical Research|August 15, 2012
Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantationTadafumi Asaoka, Shigeru Marubashi, Shogo Kobayashi, et al.
Cancer Research|June 10, 2010
Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancerTakashi Deguchi, Masahiro Tanemura, Eiji Miyoshi, et al.
Oncology Reports|January 5, 2006
TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cellsBazarragchaa Damdinsuren, Hiroaki Nagano, Motoi Kondo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 14, 2006
Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitroMasato Nakamura, Hiroaki Nagano, Takehiro Noda, et al.
Pageof 31